Related references
Note: Only part of the references are listed.Consideration of ethics in primaquine therapy against malaria transmission
J. Kevin Baird et al.
TRENDS IN PARASITOLOGY (2011)
Medications and Glucose-6-Phosphate Dehydrogenase Deficiency An Evidence-Based Review
Ilan Youngster et al.
DRUG SAFETY (2010)
The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics
Lucio Luzzatto
LANCET (2010)
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
Mamadou Bountogo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
The Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993-2007
Ali Sie et al.
GLOBAL HEALTH ACTION (2010)
High absolute bioavailability of methylene blue given as an aqueous oral formulation
Ingeborg Walter-Sack et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Artemisinin resistance on the Thai–Cambodian border
Olaf Müller et al.
LANCET (2009)
Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
Boubacar Coulibaly et al.
PLOS ONE (2009)
Turquoise to dark green organs at autopsy
Arne Warth et al.
VIRCHOWS ARCHIV (2009)
Gluclose-6-phosphate dehydrogenase deficiency
M. D. Cappellini et al.
LANCET (2008)
Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso
Augustin Zoungrana et al.
PLOS ONE (2008)
High Risk of Severe Anaemia after Chlorproguanil-Dapsone plus Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency
Caterina I. Fanello et al.
PLOS ONE (2008)
Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate
Seif Shekalaghe et al.
PLOS ONE (2007)
Methylene blue for malaria in Africa:: results from a dose-finding study in combination with chloroquine
Peter E. Meissner et al.
MALARIA JOURNAL (2006)
Pattern of cause-specific childhood mortality in a malaria endemic area of Burkina Faso
GaeL P. Hammer et al.
MALARIA JOURNAL (2006)
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins
M Akoachere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841] -: art. no. 45
PE Meissner et al.
MALARIA JOURNAL (2005)
Safety of the combination of chloroquine healthy adult men with G6PD deficiency Faso
G Mandi et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2005)
Glutathione reductase of the malarial parasite Plasmodium falciparum:: Crystal structure and inhibitor development
GN Sarma et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Methylene blue as an antimalarial agent
RH Schirmer et al.
REDOX REPORT (2003)
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline
E Davioud-Charvet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Effect of zinc supplementation on malaria and other causes of morbidity in west African children:: randomised double blind placebo controlled trial
O Müller et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
The thioredoxin system of the malaria parasite Plasmodium falciparum -: Glutathione reduction revisited
SM Kanzok et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum -: Comparison with the human enzyme
CC Böhme et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
C Peter et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
